Description
Pharmacokinetics:
Absorption: Orally absorbed, but undergoes extensive first-pass metabolism in the liver, resulting in low bioavailability (around 3-5%).
Distribution: Binds extensively to plasma proteins.
Metabolism: Extensively metabolized in the liver to various metabolites, mostly inactive.
Elimination: Primarily eliminated through the feces, with a small amount excreted in the urine.
Half-life: Approximately 6-8 hours.
Pharmacological Actions:
Antitussive: Suppresses cough reflex by acting on the cough center in the medulla oblongata.
Bronchodilatory: Relaxes bronchial smooth muscle, but the effect is weak and of limited clinical significance.
Vasodilatory: Dilates blood vessels, but the effect is weak and transient.
Other: Weak analgesic, antihistaminic, and anti-inflammatory effects.
- Pharmaceuticals
- API
- FDF
- Medicine
- Controlled
- Non controlled
Production Capacity:
Not informed
Delivery Timeframe:
Not informed
Incoterms:
Not informedPackaging Details:
Not informed
More about
Pluvia Consumer Health
500-1000
Employees
50M - 100M
Sales volume (USD)
50%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
Keywords
- Pharmaceuticals
- API
- FDF
- Medicine
- Controlled
- Non controlled Ver Mais
Contact and location
- Reza Ghorbany
- +90 545 xxxxxxxx
- Istanbul / Istanbul | Turkey